Clincosm LogoSign in Get a demo

Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes

Sponsor
Dr. Orit Hamiel (Other)
Overall Status
Unknown status
CT.gov ID
NCT02750111
Collaborator
Sheba Medical Center (Other)
50
Enrollment
1
Location
24.2
Duration (Months)
2.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Determine the incidence of hypoglycemia during / after sexual intercourse among young adults with type 1 diabetes using continuous -type sugar meter IPRO for a week.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Continuous Glucose Monitoring During Intecorse in Young Adults With Type 1 Diabetes
    Study Start Date :
    May 1, 2016
    Anticipated Primary Completion Date :
    May 8, 2018
    Anticipated Study Completion Date :
    May 8, 2018

    Outcome Measures

    Primary Outcome Measures

    1. Blood Glucose [week]

      Continuous glucose monitor for a week

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    type 1 diabetes

    Exclusion Criteria:

    type 2 diabetes other concomitant disease

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Sheba_Medical_Center Ramat Gan Israel 52621

    Sponsors and Collaborators

    • Dr. Orit Hamiel
    • Sheba Medical Center

    Investigators

    • Principal Investigator: Orit Hamiel, Prof., Sheba Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Dr. Orit Hamiel, Head department of Pediatric Endocrinology, Sheba Medical Center
    ClinicalTrials.gov Identifier:
    NCT02750111
    Other Study ID Numbers:
    • 2942.1
    First Posted:
    Apr 25, 2016
    Last Update Posted:
    Oct 19, 2017
    Last Verified:
    Oct 1, 2017
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Additional relevant MeSH terms:
    Diabetes Mellitus
    Diabetes Mellitus, Type 1

    Study Results

    No Results Posted as of Oct 19, 2017